CAT 5001

Drug Profile

CAT 5001

Alternative Names: Anti-Mesothelin Immunotoxin; CAT-5001; SS 1P; SS1(dsFv)-PE38

Latest Information Update: 17 Dec 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator National Institutes of Health (USA)
  • Class Antineoplastics; Immunotoxins
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Mesothelioma; Ovarian cancer; Pancreatic cancer

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 29 Oct 2007 Cambridge Antibody Technology has been acquired and merged into MedImmune
  • 27 Jul 2006 CAT 5001 has been licensed to Cambridge Antibody Technology worldwide
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top